Structured Contraceptive Counseling During Pregnancy
- Conditions
- ContraceptionIntrauterine DeviceLong-acting Reversible ContraceptionContraceptive ImplantCounseling
- Registration Number
- NCT05550064
- Lead Sponsor
- Dalarna University
- Brief Summary
Unintended pregnancy is common among women of fertile age, and also among those who have recently given birth. A Swedish study has shown that about 7.7% experience a new pregnancy, and that 2.5% will have an abortion between 12-24 months from childbirth.
This is a prospective observational intervention study, aiming to evaluate the effects of structured contraceptive counseling during pregnancy on uptake of contraception postpartum and more specifically on long-acting reversible contraceptive methods, and to identify and explore the provider's and patient's experiences of structured contraceptive counseling during pregnancy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 160
- 18 years or older, gestational week 30 or more, need for contraception 6 months or more after delivery
- Language barrier that affects participation when an interpreter is not available, assisted fertilization, planned sterilization of partner, use of contraception for other purposes than pregnancy prevention.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Difference in proportions of LARC use 6 months postpartum among women receiving structured contraceptive counseling compared to standard care during pregnancy. 6 months post partum Percentage
- Secondary Outcome Measures
Name Time Method New pregnancy 6, 12, 18, and 24 months postpartum Categorical (yes/no)
Outcome of new pregnancy 6, 12, 18, nd 24 months postpartum Categorical (yes/no) for planing to keep; kept; misscarriage; ectopic pregnancy; planning abortion; had an abotion
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (4)
Health Care Region Dalarna
🇸🇪Falun, Sweden
Health Care Region Värmland
🇸🇪Karlstad, Sweden
Health Care Region Uppsala
🇸🇪Uppsala, Sweden
Health Care Region Örebro Län
🇸🇪Örebro, Sweden
Health Care Region Dalarna🇸🇪Falun, SwedenSara Hogmark, MDContact